Top 10 Blue Chip Stocks To Watch For 2016

Top 10 Blue Chip Stocks To Watch For 2016: Colgate-Palmolive Company(CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide. It offers oral care products, including toothpaste, toothbrushes, and mouth rinses, as well as dental floss and pharmaceutical products for dentists and other oral health professionals; personal care products, such as liquid hand soap, shower gels, bar soaps, deodorants, antiperspirants, shampoos, and conditioners; and home care products comprising laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, dishwashing liquids, and oil soaps. The company offers its oral, personal, and home care products under the Colgate Total, Colgate Max Fresh, Colgate 360 Advisors' Opinion:

• [By Holly LaFon]

  A: The stock market is a market of individual stocks that represent fractional ownership interests in real businesses. The key to investment success is first and foremost to identify individual, highly durable businesses and then have the discipline to buy them when prices are attractive and the risk/reward trade-off is compelling. We invest in what we understand, continuing to pour over the universe of businesses within our many circles of competence that meet our management, capital allocation, business model, and valuation criteria. Some areas that we believe offer the greatest opportunity in terms of prospective returns include:

  Global market leaders such as Nike (NKE), Colgate-Palmolive (CL) and Philip Morris International (PM) that are beneficiaries of a growing global middle class and consumer culture. The global wealth effect, particularly in developing economies, is a real and very powerful force that should serve as a tailwind for these types of global brands over the long term. Well-managed financial services companies with true franchise value due to the success of their particular products or brand that have the ability and management prowess to build! market share over time in a highly fragmented marketplace. Wells Fargo and Berkshire Hathaway (BRK.B) are representative examples in this category. The depth of the recent financial crisis is well known. What is less understood is that certain market leaders used the downturn to dramatically strengthen their capital base and significantly grow their market share at the expense of weaker competitors. Certain health care-related businesses such as UnitedHealth Group and Laboratory Corporation of America that stand to benefit from growing health care spending by aging populations around the world. Workhorse technology companies such as Texas Instruments (TXN), Microsoft (MSFT) and Google that are market leaders with durable competitive moats and that also offer an attractive risk/reward proposition at
• [By WWW.DAILYFINANCE.COM]

  Svanblar/Shutterstock A common antimicrobial agent called triclosan causes liver fibrosis and cancer in laboratory mice through mechanisms also relevant to humans, researchers at the University of California, San Diego School of Medicine have found Triclosan's broad use in consumer goods -- including liquid hand soaps, toothpastes, shampoos, cosmetics, plastics, yoga mats, cutting boards and ice cream scoops -- presents "a very real risk of liver toxicity for people, as it does in mice," said Robert H. Tukey, a UC-San Diego professor and co-author of the study, published Monday in Proceedings of the National Academy of Sciences. Triclosan, a synthetic, broad-spectrum antibacterial chemical, is coming under fire because of its links to endocrine disruption that could cause infertility, impaired muscle function and now increased cancer risks. It's All Around The UC-San Diego study showed that mice exposed to triclosan for six months (roughly equivalent to 18 human years) had more and larger chemical-induced liver tumors than mice not exposed to the antimicrobial. Researchers believe triclosan may interfere with the protein responsible for detoxifying foreign! chemical! s in the body, thereby causing liver cells to proliferate and, over time, become cancerous tumors. Studies have found traces of triclosan in 97 percent of breast milk samples from lactating women and in the urine of nearly 75 percent of people tested, according to a statement by UC San Diego Health System. Triclosan is also one of the seven most frequently detected compounds in streams across the United States, the statement says. "We could reduce most human and environmental exposures by eliminating uses of triclosan that are high-volume, but of low-benefit, such as inclusion in liquid hand soaps," said Bruce D. Hammock, professor at University of California, Davis. "Yet we could also for now retain uses shown to have health value -- as in toothpaste, where the amount used is small." Colgate-P

• [By Dividend Growth Investor]

  In a previous article, I outlined that it is getting more difficult to find quality dividend paying stocks to buy. Most of the usual suspects like Kimberly-Clark (KMB) or Colgate-Palmolive (CL) are very overvalued today, which prevents me from adding to my positions there. Other companies like Chevron (CVX) are attractively valued today, but unfortunately my portfolio is overweight in them. Currently I find the oil sector to be cheap and have some of the lowest P/E ratios in the market. However, I would hate to be concentrated in one sector which is exposed to the fluctuating prices in its commodity products.

• [By Dan Caplinger]

  Moreover, it's starting to appear that Clorox has weathered a tough part of its business cycle. Throughout the industry, Procter & Gamble (NYSE: PG  ) , Colgate-Palmolive (NYSE: CL  ) , and Clorox all had to deal with rising costs for the inputs they needed to make their respective products. The companies responded by implementing price-cutting measures and passing on part of their higher costs to their customers. For its part, Clorox was able to expand its gross margins by a full perc! entage po! int, with a worse-than-normal flu season contributing to sales. Now that input-cost inflation is easing, P&G and Clorox expect to see better profitability, with growth starting to approach the faster rates that Colgate has enjoyed.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-10-blue-chip-stocks-to-watch-for-2016.html